Online citations, reference lists, and bibliographies.
Please confirm you are human
(Sign Up for free to never see this)
← Back to Search

European Society Of Gastrointestinal Endoscopy (ESGE) Guideline: Prophylaxis Of Post-ERCP Pancreatitis.

J-M Dumonceau, A. Andriulli, J. Deviére, A. Mariani, J. Rigaux, T. Baron, P. Testoni
Published 2010 · Medicine

Save to my Library
Download PDF
Analyze on Scholarcy
Share
Pancreatitis is the most common complication of endoscopic retrograde cholangiopancreatography (ERCP). Risk factors for post-ERCP pancreatitis (PEP) are both patient-related and procedure-related. Identification of patients at high risk for PEP is important in order to target prophylactic measures. Prevention of PEP includes administration of nonsteroidal inflammatory drugs (NSAIDs), use of specific cannulation techniques, and placement of temporary pancreatic stents. The aim of this guideline commissioned by the European Society of Gastrointestinal Endoscopy (ESGE) is to provide practical, graded, recommendations for the prevention of PEP.
This paper references
10.1067/MGE.2003.52
Biliary sphincterotomy plus dilation with a large balloon for bile duct stones that are difficult to extract.
G. Ersõz (2003)
10.1056/NEJM199703273361317
Complications of endoscopic biliary sphincterotomy.
Z. Tulassay (1997)
10.1055/S-2004-826077
Precut papillotomy versus persistence in difficult biliary cannulation: a prospective randomized trial.
S-J Tang (2005)
10.1067/MGE.2002.122614
Octreotide versus hydrocortisone versus placebo in the prevention of post-ERCP pancreatitis: a multicenter randomized controlled trial.
S. Manolakopoulos (2002)
10.1016/S0016-5107(92)70430-1
Pancreatitis following bile duct sphincter of Oddi manometry: utility of the aspirating catheter.
S. Sherman (1992)
10.1111/j.1572-0241.2006.00959.x
Effect of Octreotide Administration in the Prophylaxis of Post-ERCP Pancreatitis and Hyperamylasemia: A Multicenter, Placebo-Controlled, Randomized Clinical Trial
Z. Li (2007)
10.1111/j.1572-0241.2001.04092.x
A randomized, double blind study of interleukin 10 for the prevention of ERCP-induced pancreatitis
J. Dumot (2001)
10.1016/j.gie.2007.08.047
Large-diameter biliary orifice balloon dilation to aid in endoscopic bile duct stone removal: a multicenter series.
S. Attasaranya (2008)
10.1016/S0016-5085(00)82864-4
Development of a sleeve sensor for measurement of sphincter of Oddi motility.
A. Craig (2000)
10.1055/S-2003-42614
Risk factors for pancreatitis following endoscopic retrograde cholangiopancreatography: a meta-analysis.
E. Masci (2003)
10.1159/000106774
Pancreatic Duct Stents in the Prophylaxis of Pancreatic Damage after Endoscopic Retrograde Cholangiopancreatography: A Systematic Analysis of Benefits and Associated Risks
A. Andriulli (2007)
10.1055/S-2006-945036
Carbon dioxide insufflation for more comfortable endoscopic retrograde cholangiopancreatography: a randomized, controlled, double-blind trial.
M. Bretthauer (2007)
10.1023/B:DDAS.0000020511.98230.20
Role of Osmolality of Contrast Media in the Development of Post-ERCP Pancreatitis: A Metanalysis
S. George (2004)
10.1016/S0016-5107(02)70184-3
Safety and outcome of endoscopic snare excision of the major duodenal papilla.
I. Norton (2002)
10.1155/2004/741912
Patterns of use of endoscopic retrograde cholangiopancreatography in a Canadian province.
R. Hilsden (2004)
10.1016/J.GIE.2005.05.016
Relationship among hospital ERCP volume, length of stay, and technical outcomes.
S. Varadarajulu (2006)
10.1016/J.GIE.2008.03.142
Carbon Dioxide (CO2) Insufflation during ERCP for the Reduction of Post-procedure Pain: Preliminary Results of a Randomized, Double-blind Controlled Trial
R. Keswani (2008)
10.1097/00006676-200408000-00018
Natural beta-carotene for the prevention of post-ERCP pancreatitis.
A. Lavy (2004)
10.1016/j.gie.2008.11.044
Prospective trial comparing solid-state catheter and water-perfusion triple-lumen catheter for sphincter of Oddi manometry done at the time of ERCP.
P. Draganov (2009)
10.1016/S0016-5107(99)70387-1
Prophylactic effect of somatostatin on post-ERCP pancreatitis: a randomized controlled trial.
R. Poon (1999)
10.1055/S-1999-13660
Twenty-four-hour serum amylase predicting pancreatic reaction after endoscopic sphincterotomy.
P. Testoni (1999)
10.3748/WJG.V13.I28.3855
Relationship between post-ERCP pancreatitis and the change of serum amylase level after the procedure.
K. Ito (2007)
10.1055/s-2007-967040
Large-diameter balloon dilation after endoscopic sphincterotomy for removal of difficult bile duct stones.
S. Misra (2008)
10.1046/j.1365-2036.2001.01015.x
Octreotide 24‐h prophylaxis in patients at high risk for post‐ERCP pancreatitis: results of a multicenter, randomized, controlled trial
P. Testoni (2001)
Role of nonsteroidal anti-inflammatory drugs in the prevention of post-ERCP pancreatitis: a meta-analysis.
Hui-fen Dai (2009)
10.1002/14651858.CD004890.PUB2
Endoscopic balloon sphincter dilation (sphincteroplasty) versus sphincterotomy for common bile duct stones.
B. Weinberg (2006)
10.1038/ajg.2009.345
An Analysis of the Factors Associated With the Development of Complications in Patients Undergoing Precut Sphincterotomy: A Prospective, Controlled, Randomized, Multicenter Study
G. Manes (2009)
Use of octreotide-acetate in preventing pancreatitis-like changes following therapeutic endoscopic retrograde cholangiopancreatography.
M. Duvnjak (1999)
Carbon dioxide ( CO 2 ) insufflation during ERCP for the reduction of post - procedure pain : preliminary results of a randomized , double - blind controlled trial
R Keswani (2008)
10.1038/ajg.2009.269
Can a Wire-Guided Cannulation Technique Increase Bile Duct Cannulation Rate and Prevent Post-ERCP Pancreatitis?: A Meta-Analysis of Randomized Controlled Trials
V. Cennamo (2009)
10.1055/S-2005-870511
Is the supine position as safe and effective as the prone position for endoscopic retrograde cholangiopancreatography? A prospective randomized study.
V. Terruzzi (2005)
Early recognition of post-ERCP pancreatitis by clinical assessment and serum pancreatic enzymes.
K. Gottlieb (1996)
10.1016/S0016-5107(02)70431-8
Gabexate or somatostatin administration before ERCP in patients at high risk for post-ERCP pancreatitis: a multicenter, placebo-controlled, randomized clinical trial.
A. Andriulli (2002)
10.1136/gut.49.5.686
Can endoscopic papillary balloon dilation really preserve sphincter of Oddi function?
I. Yasuda (2001)
10.1016/S0016-5107(04)02013-9
Does prophylactic pancreatic stent placement reduce the risk of post-ERCP acute pancreatitis? A meta-analysis of controlled trials.
P. Singh (2004)
10.1111/j.1572-0241.2004.30151.x
Endoscopic Balloon Dilation of the Biliary Sphincter Compared to Endoscopic Biliary Sphincterotomy for Removal of Common Bile Duct Stones During ERCP: A Metaanalysis of Randomized, Controlled Trials
T. Baron (2004)
10.1016/S0016-5107(98)70121-X
Major early complications from diagnostic and therapeutic ERCP: a prospective multicenter study.
S. Loperfido (1998)
10.1016/J.GIE.2007.02.033
Endoscopic sphincterotomy plus large-balloon dilation versus endoscopic sphincterotomy for removal of bile-duct stones.
J. Heo (2007)
A multicenter, randomized, controlled trial to evaluate the effect of prophylactic octreotide on ERCP-induced pancreatitis.
J. Sternlieb (1992)
10.1016/J.GIE.2007.02.055
Efficacy of postprocedure administration of gabexate mesylate in the prevention of post-ERCP pancreatitis: a randomized, controlled, multicenter study.
G. Manes (2007)
10.1001/ARCHSURG.1993.01420170122019
A clinically based classification system for acute pancreatitis. Summary of the International Symposium on Acute Pancreatitis, Atlanta, Ga, September 11 through 13, 1992.
E. L. Bradley (1993)
10.1055/S-2007-966723
Risk factors for complication following ERCP; results of a large-scale, prospective multicenter study.
E. Williams (2007)
10.1016/S0016-5107(02)70178-8
Nifedipine for prevention of post-ERCP pancreatitis: a prospective, double-blind randomized study.
F. Prat (2002)
10.3748/WJG.14.5595
Pancreatic guidewire placement for achieving selective biliary cannulation during endoscopic retrograde cholangio-pancreatography.
K. Ito (2008)
10.1055/S-2003-41576
Prospective randomized pilot trial of selective biliary cannulation using pancreatic guide-wire placement.
S. Maeda (2003)
10.1016/j.gie.2009.10.055
Prophylaxis of post-ERCP pancreatitis: a practice survey.
J. Dumonceau (2010)
10.1007/s00535-008-2272-8
Epinephrine sprayed on the papilla for prevention of post-ERCP pancreatitis
Mitsunobu Matsushita (2008)
10.1016/J.GIE.2006.10.021
Frequency and severity of post-ERCP pancreatitis correlated with extent of pancreatic ductal opacification.
Y. K. Cheon (2007)
10.1016/S0016-5107(03)02540-9
The effect of lidocaine sprayed on the major duodenal papilla on the frequency of post-ERCP pancreatitis.
Jeremy J. Schwartz (2004)
10.1007/s10620-008-0709-9
Nitroglycerin in the Prevention of Post-ERCP Pancreatitis: A Meta-Analysis
Liming Shao (2008)
10.1007/s00464-007-9738-2
Low-dose heparin for the prevention of post-ERCP pancreatitis: a randomized placebo-controlled trial
O. Barkay (2007)
10.1007/s00535-006-1986-8
Comparison between ulinastatin and gabexate mesylate for the prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis: a prospective, randomized trial
T. Ueki (2006)
10.1111/j.1440-1746.2006.04085.x
Ulinastatin shows preventive effect on post‐endoscopic retrograde cholangiopancreatography pancreatitis in a multicenter prospective randomized study
H. Fujishiro (2006)
10.1016/J.GIE.2005.04.020
Prospective, randomized, controlled trial of prophylactic pancreatic stent placement for endoscopic snare excision of the duodenal ampulla.
G. Harewood (2005)
10.1159/000151999
Prophylactic Corticosteroids Do Not Prevent Post-ERCP Pancreatitis: A Meta-Analysis of Randomized Controlled Trials
Y. Bai (2008)
10.1055/S-2003-39677
Reduced risk for pancreatitis after endoscopic microtransducer manometry of the sphincter of Oddi: a randomized comparison with the perfusion manometry technique.
T. Wehrmann (2003)
10.1136/gut.52.12.1768
Intravenous bolus somatostatin after diagnostic cholangiopancreatography reduces the incidence of pancreatitis associated with therapeutic endoscopic retrograde cholangiopancreatography procedures: a randomised controlled trial
R. Poon (2003)
10.1136/bmj.323.7308.334
A new system for grading recommendations in evidence based guidelines
R. Harbour (2001)
10.1055/S-2007-995317
No difference between supine and prone position for ERCP in conscious sedated patients: a prospective randomized study.
A. Tringali (2008)
10.1016/j.gie.2008.09.037
Timing of precut procedure does not influence success rate and complications of ERCP procedure: a prospective randomized comparative study.
V. Cennamo (2009)
10.1016/J.GIE.2007.03.1045
A randomized controlled trial of pentoxifylline for the prevention of post-ERCP pancreatitis.
D. Kapetanos (2007)
Octreotide in the prevention of pancreatic damage induced by endoscopic sphincterotomy.
P. Hardt (2000)
10.1016/S1542-3565(04)00295-2
Prophylaxis of ERCP-related pancreatitis: a randomized, controlled trial of somatostatin and gabexate mesylate.
A. Andriulli (2004)
10.1111/j.1365-2036.2009.03978.x
Meta‐analysis: nitroglycerin for prevention of post‐ERCP pancreatitis
U. Bang (2009)
10.1016/J.GIE.2006.03.934
Twenty-four hour prophylaxis with increased dosage of octreotide reduces the incidence of post-ERCP pancreatitis.
K. Thomopoulos (2006)
10.1016/j.gie.2008.07.040
Evaluation of recombinant platelet-activating factor acetylhydrolase for reducing the incidence and severity of post-ERCP acute pancreatitis.
S. Sherman (2009)
10.1016/S1542-3565(04)00671-8
Ulinastatin for pancreatitis after endoscopic retrograde cholangiopancreatography: a randomized, controlled trial.
T. Tsujino (2005)
10.1097/MPA.0b013e3181733721
The Prophylactic Effect of Somatostatin on Post-Therapeutic Endoscopic Retrograde Cholangiopancreatography Pancreatitis: A Randomized, Multicenter Controlled Trial
K. Lee (2008)
10.1016/S1091-255X(01)80059-7
Post-ERCP pancreatitis: Reduction by routine antibiotics
S. Räty (2001)
10.1097/MPA.0b013e31819777d5
Efficacy of Recombinant Human Interleukin-10 in Prevention of Post-Endoscopic Retrograde Cholangiopancreatography Pancreatitis in Subjects With Increased Risk
S. Sherman (2009)
10.1055/S-2000-7034
Provision of ERCP services and training in the United Kingdom.
M. Allison (2000)
10.1111/j.1572-0241.2002.05829.x
An assessment of the learning curve for precut biliary sphincterotomy
G. Harewood (2002)
Short 5Fr vs long 3Fr pancreatic stents in patients at high risk for post- endoscopic cholangiopancreatography pancreatitis
P Chahal (2009)
A multicenter, randomized, controlled trial to evaluate the effect of prophylactic octreotide on ERCP-induced pancreatitis.
K. Stas (1993)
10.1111/j.1572-0241.2001.03594.x
Complications of diagnostic and therapeutic ERCP: a prospective multicenter study
E. Masci (2001)
10.1007/s00534-007-1262-1
Sleeve sphincter of Oddi (SO) manometry: a new method for characterizing the motility of the sphincter of Oddi.
M. Kawamoto (2008)
A randomized , double blind study of interleukin 10 for the prevention of ERCP - induced pancreati
JA Dumot (2001)
10.1056/NEJM199609263351302
Gabexate for the prevention of pancreatic damage related to endoscopic retrograde cholangiopancreatography. Gabexate in digestive endoscopy--Italian Group.
G. Cavallini (1996)
10.1016/j.gie.2008.11.022
Quality indicators, including complications, of ERCP in a community setting: a prospective study.
Joshua B Colton (2009)
10.1016/J.GIE.2009.03.275
The Early Use of the Double-Wire Technique to Facilitate Difficult Biliary Cannulation and Its Impact On Post-ERCP Pancreatitis
S. Patel (2009)
Nacetylcysteine does not prevent post-endoscopic retrograde cholangiopancreatography hyperamylasemia and acute pancreatitis
J Milewski (2006)
Can somatostatin prevent injection pancreatitis after ERCP?
B. Persson (1992)
10.1016/S0016-5107(95)90002-0
The use of a long-acting somatostatin analogue (octreotide) for prophylaxis of acute pancreatitis after endoscopic sphincterotomy.
R. Arcidiacono (1994)
10.1007/S11894-007-0013-4
Solid state biliary manometry catheter: Impact on diagnosis and post-study pancreatitis
M. Frenz (2007)
10.1111/j.1365-2036.2008.03756.x
Meta‐analysis: allopurinol in the prevention of postendoscopic retrograde cholangiopancreatography pancreatitis
Y. Bai (2008)
10.1055/S-2003-36403
Double guide wire placement for endoscopic pancreaticobiliary procedures.
T. Gyökeres (2003)
10.1136/gut.2007.140756
A meta-analysis of rectal NSAIDs in the prevention of post-ERCP pancreatitis
B. Elmunzer (2008)
10.1016/J.GIE.2009.03.869
Guidewire Use for Prevention of Post ERCP Pancreatitis: A Meta-Analysis of Randomized Controlled Trials
A. Choudhary (2009)
10.1016/S0016-5107(91)70740-2
Endoscopic sphincterotomy complications and their management: an attempt at consensus.
P. Cotton (1991)
10.1016/j.gie.2008.01.034
Pre-ERCP infusion of semapimod, a mitogen-activated protein kinases inhibitor, lowers post-ERCP hyperamylasemia but not pancreatitis incidence.
D. V. van Westerloo (2008)
10.3748/WJG.V13.I15.2179
Small sphincterotomy combined with papillary dilation with large balloon permits retrieval of large stones without mechanical lithotripsy.
Atsushi Minami (2007)
10.1055/S-2007-966784
Balloon sphincteroplasty for removing difficult bile duct stones.
A. Maydeo (2007)
10.1016/j.gie.2009.10.049
Double-guidewire technique for difficult bile duct cannulation: why not insert a prophylactic pancreatic stent?
T. Nguyen-Tang (2010)
10.1590/S0100-879X2006000100010
Clinical trial of gabexate in the prophylaxis of post-endoscopic retrograde cholangiopancreatography pancreatitis.
G-S Xiong (2006)
10.1038/ajg.2009.693
Does Wire-Guided Cannulation Prevent Post-ERCP Pancreatitis?: A Meta-Analysis
M. Madhoun (2010)
10.1016/S1590-8658(06)80037-X
Prevention of post-ERCP pancreatitis with somatostatin versus gabexate mesylate: A randomized placebo controlled multicenter study
S. Benvenuti (2006)
10.1097/MPA.0b013e31817f528f
Preventive Effects of Ulinastatin on Post-Endoscopic Retrograde Cholangiopancreatography Pancreatitis in High-Risk Patients: A Prospective, Randomized, Placebo-Controlled Trial
J. Yoo (2008)
10.1016/J.GIE.2008.03.995
5 Fr Prophylactic Pancreatic Stents Are Easier to Place and Require Fewer Guide Wires Than 3 Fr Stents
S. Fehmi (2008)
10.1016/S0016-5107(05)01574-9
Intravenous N-acetylcysteine does not prevent post-ERCP pancreatitis.
P. Katsinelos (2005)
10.1067/MGE.2003.124
Does a pancreatic duct stent prevent post-ERCP pancreatitis? A prospective randomized study.
A. Fazel (2003)
10.1016/S0016-5107(02)70112-0
Risk factors for complications after performance of ERCP.
J. Vandervoort (2002)
10.1055/S-2006-944962
Primary precutting versus conventional over-the-wire sphincterotomy for bile duct access: a prospective randomized study.
A. de Weerth (2006)
10.1016/J.GIE.2008.03.344
Role of Double Guide Wire Cannulation During ERCP
Shahzad Iqbal (2008)
10.1111/j.1440-1746.2003.03297.x
Can somatostatin prevent post‐ERCP pancreatitis? Results of a randomized controlled trial
D. Arvanitidis (2004)
10.1016/j.cgh.2008.01.012
Risk of post-endoscopic retrograde cholangiopancreatography pancreatitis and ways to prevent it: old myths, a current need? The case of allopurinol.
A. Andriulli (2008)
10.1055/S-2004-814185
Botulinum toxin injection after biliary sphincterotomy.
A. Gorelick (2004)
10.1016/j.gie.2008.12.050
Carbon dioxide insufflation during ERCP for reduction of postprocedure pain: a randomized, double-blind, controlled trial.
J. Maple (2009)
Twenty-four-hour serum amylase predicting pancreatic reaction after endoscopic sphincterot
PA Testoni (1992)
10.1159/000201021
Prospective randomized trial of the effect of nifedipine on pancreatic irritation after endoscopic retrograde cholangiopancreatography.
J. A. Sand (1993)
10.1007/s00535-010-0268-7
Can pancreatic duct stenting prevent post-ERCP pancreatitis in patients who undergo pancreatic duct guidewire placement for achieving selective biliary cannulation? A prospective randomized controlled trial
K. Ito (2010)
An Experimental and Clinical Study
R. Berger (1966)
10.1016/S0016-5107(93)70217-5
Effect of prophylactic main pancreatic duct stenting on the incidence of biliary endoscopic sphincterotomy-induced pancreatitis in high-risk patients.
A. Smithline (1993)
10.1055/s-2007-995652
The learning curve for safety and success of precut sphincterotomy for therapeutic ERCP: a single endoscopist's experience.
T. Akaraviputh (2008)
10.1016/J.CGH.2007.07.008
Prophylaxis of post-endoscopic retrograde cholangiopancreatography pancreatitis by an endoscopic pancreatic spontaneous dislodgement stent.
A. Sofuni (2007)
A clinically based classification system for acute pancreatitis.
Bradley Rd (1993)
10.1016/J.GIE.2007.01.018
Pure versus mixed electrosurgical current for endoscopic biliary sphincterotomy: a meta-analysis of adverse outcomes.
D. Verma (2007)
10.1016/j.cgh.2009.05.002
Short 5Fr vs long 3Fr pancreatic stents in patients at risk for post-endoscopic retrograde cholangiopancreatography pancreatitis.
Prabhleen Chahal (2009)
10.1016/j.gie.2008.10.046
Nafamostat mesylate in the prevention of post-ERCP pancreatitis and risk factors for post-ERCP pancreatitis.
C. Choi (2009)
10.1016/S0016-5107(96)70163-3
Alterations in pancreatic ductal morphology following polyethylene pancreatic stent therapy.
M. Smith (1996)
Rectal administration of NSAIDs in the prevention of post-ERCP pancreatitis: a complementary meta-analysis.
M. Zheng (2008)
10.1016/S0016-5085(98)70031-9
Pancreatic stenting prevents pancreatitis after biliary sphincterotomy in patients with sphincter of Oddi dysfunction.
P. Tarnasky (1998)
10.1067/MGE.2002.122616
Complications of endoscopic sphincterotomy: can heparin prevent acute pancreatitis after ERCP?
T. Rabenstein (2002)
The influence of somatostatin on pancreatic irritation after pancreatography. An experimental and clinical study
A Saari (1988)
10.1016/j.gie.2009.08.007
Guidewire versus conventional contrast cannulation of the common bile duct for the prevention of post-ERCP pancreatitis: a systematic review and meta-analysis.
J. Cheung (2009)
10.1097/MPA.0b013e31816857e3
Meta-Analysis of Prophylactic Allopurinol Use in Post-Endoscopic Retrograde Cholangiopancreatography Pancreatitis
M. Zheng (2008)
10.1016/S0016-5107(90)71115-7
Sphincter of Oddi manometry: decreased risk of clinical pancreatitis with use of a modified aspirating catheter.
S. Sherman (1990)
The value of serum amylase and elastase measurements in the prediction of post-ERCP acute pancreatitis.
D. Kapetanos (2007)
10.1136/gut.2006.097543
Are we meeting the standards set for endoscopy? Results of a large-scale prospective survey of endoscopic retrograde cholangio-pancreatograph practice
E. Williams (2007)
10.1053/gast.2001.26047
Interleukin 10 reduces the incidence of pancreatitis after therapeutic endoscopic retrograde cholangiopancreatography.
J. Deviére (2001)
10.1111/j.1572-0241.2006.00380.x
Risk Factors for Post-ERCP Pancreatitis: A Prospective Multicenter Study
Chi-Liang Cheng (2006)
10.1053/J.GASTRO.2004.07.017
Endoscopic balloon dilation compared with sphincterotomy for extraction of bile duct stones.
J. Disario (2004)
10.1016/J.GIE.2006.07.031
Pancreatic-stent placement for prevention of post-ERCP pancreatitis: a cost-effectiveness analysis.
A. Das (2007)
10.1007/s00464-008-9969-x
Quantitative assessment of technical proficiency in performing needle-knife precut papillotomy
H. Fukatsu (2008)
10.1111/j.1572-0241.2007.01279.x
Incidence Rates of Post-ERCP Complications: A Systematic Survey of Prospective Studies
A. Andriulli (2007)
10.1016/J.GIE.2006.01.058
A survey of physician practices on prophylactic pancreatic stents.
Stephen P. Brackbill (2006)
10.1016/S0016-5107(04)00159-2
Low-molecular-weight heparin does not prevent acute post-ERCP pancreatitis.
T. Rabenstein (2004)
10.1186/1471-230X-8-6
Meta-analysis of prophylactic corticosteroid use in post-ERCP pancreatitis
M. Zheng (2008)
10.3748/WJG.V12.I23.3751
N-acetylcysteine does not prevent post-endoscopic retrograde cholangiopancreatography hyperamylasemia and acute pancreatitis.
J. Milewski (2006)
Guidelines for PEP prophylaxis.
Dumonceau J-M (2010)
10.1016/S0016-5107(03)02530-6
Pancreatic stent insertion: consequences of failure and results of a modified technique to maximize success.
M. Freeman (2004)
10.1016/j.gie.2009.03.031
Double-guidewire technique for difficult bile duct cannulation: a multicenter randomized, controlled trial.
A. Herreros de Tejada (2009)
10.1016/S0016-5107(98)70318-9
Effects of bolus somatostatin in preventing pancreatitis after endoscopic pancreatography: results of a randomized study.
J. Bordas (1998)
10.1038/ajg.2008.5
Risk Factors for ERCP-Related Complications: A Prospective Multicenter Study
P. Wang (2009)
10.1067/MGE.2001.111390
Pain at 24 hours associated with amylase levels greater than 5 times the upper normal limit as the most reliable indicator of post-ERCP pancreatitis.
P. Testoni (2001)
10.1046/j.1440-1746.2001.02547.x
Prediction of pancreatitis following endoscopic retrograde cholangiopancreatography by the 4‐h post procedure amylase level
P. R. Thomas (2001)



This paper is referenced by
10.1097/SMJ.0b013e3181683eff
Capsule Endoscopy: A Review
M. Sachdev (2008)
10.4321/s1130-01082013000600001
Precut: two (combined techniques) better than one.
Juan Ángel González-Martín (2013)
10.1007/s10190-012-0246-4
Endoscopie et antiagrégants plaquettaires: d’après les recommandations de la Société européenne d’endoscopie gastro-intestinale
C. Boustière (2012)
10.1055/s-0031-1291543
Learning, techniques, and complications of endoscopic ultrasound (EUS)-guided sampling in gastroenterology: European Society of Gastrointestinal Endoscopy (ESGE) Technical Guideline.
M. Pólkowski (2012)
10.17235/reed.2016.4348/2016
Early precut is as efficient as pancreatic stent in preventing post-ERCP pancreatitis in high-risk subjects - A randomized study.
David Zagalsky (2016)
10.1016/j.jfma.2020.10.034
Efficacy of gabexate mesilate in preventing post endoscopic retrograde cholangiopancreatography pancreatitis: A meta-analysis of randomized clinical trials.
Yu-Jui Chiu (2020)
10.4172/2165-7092.1000123
Prevention of post-ERCP Pancreatitis
Takeshi Tsujino (2013)
10.1556/OH.2015.30062
[Pediatric pancreatitis. Evidence based management guidelines of the Hungarian Pancreatic Study Group].
A. Párniczky (2015)
10.1055/s-0034-1377875
Prophylaxis of post-ERCP pancreatitis: European Society of Gastrointestinal Endoscopy (ESGE) Guideline - updated June 2014.
J. Dumonceau (2014)
10.1055/s-0034-1385420
[Endoscopic management of surgical biliary complications].
Frank Thomas Kolligs (2014)
10.1111/apt.13744
Systematic review: periprocedural hydration in the prevention of post‐ERCP pancreatitis
X. J. N. M. Smeets (2016)
10.1038/srep46650
Efficacy and safety of rectal nonsteroidal anti-inflammatory drugs for prophylaxis against post-ERCP pancreatitis: a systematic review and meta-analysis
Yichao Hou (2017)
10.3906/sag-1502-104
Rectal or intramuscular diclofenac reduces the incidence of pancreatitis afterendoscopic retrograde cholangiopancreatography.
Ramazan Ucar (2016)
10.4172/2165-7092.1000185
Preoperative Biliary Drainage of Jaundiced Patients with Pancreatic Head Cancer: A Routine or Selective Strategy
F. Tshijanu (2017)
10.1055/s-0030-1256315
Biliary stents: models and methods for endoscopic stenting.
J-M Dumonceau (2011)
10.1055/s-0034-1390743
Intramuscular diclofenac for the prevention of post-ERCP pancreatitis: a randomized trial.
S. W. Park (2015)
10.1007/s10620-012-2269-2
Use of a Pancreatic Duct Stent or Guidewire Facilitates Bile Duct Access with Low Rates of Precut Sphincterotomy: A Randomized Clinical Trial
G. Coté (2012)
10.1007/978-2-8178-0237-4_19
Cathétérisme bilio-pancréatique et sphinctérotomie endoscopique
F. Prat (2011)
10.1007/978-3-662-45194-6_4
Endoskopische retrograde Cholangiopankreatikographie
Rudolf Mennigen (2016)
10.1007/s12664-018-0841-1
Pre-endoscopic retrograde cholangiopancreatography (ERCP) administration of rectal indomethacin in unselected patients to reduce post-ERCP pancreatitis: A systematic review and meta-analysis
Rajat Garg (2018)
10.1007/s00464-012-2487-x
Pancreatic duct stenting for the duration of ERCP only does not prevent pancreatitis after accidental pancreatic duct cannulation: a prospective randomized trial
R. Conigliaro (2012)
10.1097/MPA.0000000000000245
Prevention of Post-Endoscopic Retrograde Cholangiopancreatography Pancreatitis: A Cost-effectiveness Analysis
D. Nicolás-Pérez (2015)
10.1007/s10620-016-4251-x
No Benefit of Oral Diclofenac on Post-Endoscopic Retrograde Cholangiopancreatography Pancreatitis
Hirotoshi Ishiwatari (2016)
10.1007/s10190-013-0369-2
Pathologies biliopancréatiques, tumeurs sous-muqueuses, échoendoscopie — endothérapie biliopancréatique
C. Lefort (2013)
10.1186/s12876-015-0381-4
Wire-guided cannulation over a pancreatic stent versus double guidewire technique in patients with difficult biliary cannulation
M. Yang (2015)
10.3904/kjim.2013.28.2.141
Can postendoscopic retrograde cholangiopancreatography pancreatitis be prevented by a pharmacological approach?
Y. K. Cheon (2013)
10.1016/j.gtc.2011.12.010
The role of endoscopic retrograde cholangiopancreatography in patients with pancreatic disease.
J. Buxbaum (2012)
10.3748/wjg.v18.i14.1635
Randomized controlled trial of pancreatic stenting to prevent pancreatitis after endoscopic retrograde cholangiopancreatography.
Yoshiaki Kawaguchi (2012)
10.1097/MD.0000000000000235
Sudden Death After Endoscopic Retrograde Cholangiopancreatography (ERCP)—Case Report and Literature Review
G. Hauser (2014)
10.3109/00365521.2011.594085
Contemporary use of endoscopic retrograde cholangiopancreatography (ERCP): A Norwegian prospective, multicenter study
T. Glomsaker (2011)
10.4253/wjge.v4.i9.398
Comparison between needle-knife fistulotomy and standard cannulation in ERCP.
M. Ayoubi (2012)
10.1016/j.gie.2016.04.018
Metal versus plastic stents for drainage of malignant biliary obstruction before primary surgical resection.
T. Song (2016)
See more
Semantic Scholar Logo Some data provided by SemanticScholar